Vaccine Therapy and Sargramostim in Treating Patients With Pancreas Cancer That Cannot Be Removed By Surgery | MicrobiomeTrials← Back to trialsNCT00669734
Vaccine Therapy and Sargramostim in Treating Patients With Pancreas Cancer That Cannot Be Removed By Surgery
RecruitingPHASE1INTERVENTIONAL
Trial Details
Start: 2010-02-01Est. Completion: 2021-09-02
Enrollment target: 18 participants Locations- Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, United States
Other microbiome trials you might be interested in
Solid Tumor
Genes contain genetic code which tell the body which proteins to make. Some types of cancer are caused by changes, or mu…
Westwood, United StatesCompleted Jun 18, 2026
Pancreatic Ductal Adenocarcinoma
Chiauranib , which simultaneously targets against VEGFR/Aurora B/CSF-1R, several key kinases involved in tumor angiogene…
Shanghai, ChinaEst. completion Feb 28, 2027